ArticleHemaSphere2021

Targeting IDH1 and IDH2 Mutations in Acute Myeloid Leukemia: Emerging Options and Pending Questions.

Bas J WoutersPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.